Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Charmacy Pharmaceutical Co., Ltd. has announced a delay in the publication of its circular related to the New Framework Agreements, now expected to be released by December 13, 2024. The extension is required to finalize certain information, ensuring comprehensive details for investors. This delay might affect stakeholders anticipating updates in the company’s strategic agreements.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.